Population Health Management 2024
Sample of Decisions Made by Large Acute Care Organizations Center on a Few Broad Platforms
In recent years, purchasing energy in the population health management (PHM) market has cooled among large acute care organizations—only 10% of interviewed organizations report a recent or in-progress PHM purchase decision. This trend is largely the result of healthcare organizations deprioritizing initial investments in new solutions and instead focusing on cost reduction and improved ROI through vendor consolidation, better data access and utilization, and improved functionality that supports value-based initiatives (i.e., care management, whole-person care, downside risk contracts). Physician-led ACOs don’t always face the same challenges as large acute care organizations (the majority of the sample included in this data set), so they may make decisions differently. With fewer decisions being made for acute care organizations, there is greater pressure on vendors to more thoroughly prove their platform’s capabilities during the RFP process. To help healthcare organizations navigate purchasing decisions in this market, this report draws from 40 purchase decisions validated by KLAS between July 2022 and June 2024 to examine (1) which vendors’ customer bases are growing, being maintained, or decreasing amid market shifts and (2) which factors contribute to current buying energy. Satisfaction data from current customers is also included.
If you don't have a login, getting started is easy.
Key Findings:
- Market Energy Mostly Focused on Arcadia, Innovaccer & Lightbeam for Broad Functionality That Supports Value-Based Initiatives; Epic Considered for Consolidation
- Due to Lack of Optimization, Lightbeam, Arcadia, Oracle Health & HealthEC* Most Often Up for Replacement
- Looking Forward, Customers of Oracle Health, Health Catalyst & NextGen Healthcare* Need Improved Innovation
*Limited data
Writer
Carlisa Cramer
Designer
Nikki Christensen
Project Manager
Andrew Wright
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.